image
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 47.56
3.68 %
$ 2.83 B
Market Cap
-13.21
P/E
CASH FLOW STATEMENT
-64.1 M OPERATING CASH FLOW
55.01%
-3.07 M INVESTING CASH FLOW
-6.07%
6.89 M FINANCING CASH FLOW
656.31%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Twist Bioscience Corporation
image
Net Income -209 M
Depreciation & Amortization 31.4 M
Capital Expenditures -5.08 M
Stock-Based Compensation 50.9 M
Change in Working Capital 15.4 M
Others 57.6 M
Free Cash Flow -69.2 M

Cash Flow

Millions
Sep-2024 Sep-2023 Sep-2022 Sep-2021 Sep-2020 Sep-2019 Sep-2018 Sep-2017 Sep-2016
OPERATING CASH FLOW
Net Income (208.7) (204.6) (217.9) (152.1) (139.9) (107.7) (71.2) (59.3) (44.1)
Depreciation & Amortization 31.4 29.3 16.5 9.8 6.7 6.1 5.7 5.0 4.2
Deferred Income Tax 0 (0.4) 0 0.6 (0.2) (1.1) 42 K 0.8 68 K
Stock Based Compensation 50.9 30.3 79.7 37.0 17.1 11.2 3.0 1.9 0.9
Other Operating Activities 46.9 4.0 2.7 1.9 (0.7) 0.5 0.6 0.5 0.2
Change in Working Capital 15.4 (1.0) (5.4) (9.4) (25.2) 3.0 (4.2) (0.1) 0.2
Cash From Operations (64.1) (142.5) (124.4) (112.2) (142.3) (87.9) (66.2) (51.3) (38.6)
INVESTING CASH FLOW
Capital Expenditures (5.1) (27.8) (101.9) (27.1) (9.9) (14.8) (3.7) (6.6) (6.2)
Other Items 2.0 78.4 (131.1) 183.2 (104.8) (90.1) 30.6 (3.3) (27.1)
Cash From Investing Activities (3.1) 50.6 (232.9) 156.2 (114.7) (104.8) 26.9 (9.9) (33.3)
FINANCING CASH FLOW
Common Stock Repurchased (4.0) (4.4) (7.8) (10.8) (2.4) 0 0 0 0
Total Debt Repaid 0 0 (1.6) (3.3) (3.3) (2.5) 0 (2.0) 7.2
Dividends Paid 0 0 0 0 0 0 0 0 0
Other Financing Activities 10.9 5.3 10.0 19.5 13.9 4.9 88.8 65.8 124.7
Cash From Financing Activities 6.9 0.9 270.5 329.2 303.7 158.6 88.8 63.8 69.6
CHANGE IN CASH
Net Change In Cash (60.1) (91.0) (87.1) 373.1 46.8 (34.1) 49.5 2.6 (2.3)
FREE CASH FLOW
Free Cash Flow (69.2) (170.3) (226.2) (139.3) (152.1) (102.7) (69.9) (57.9) (44.8)